Tze-Peng Lim

1.2k total citations
34 papers, 944 citations indexed

About

Tze-Peng Lim is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Tze-Peng Lim has authored 34 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Medicine, 23 papers in Pharmacology and 10 papers in Epidemiology. Recurrent topics in Tze-Peng Lim's work include Antibiotic Resistance in Bacteria (27 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Antibiotic Use and Resistance (7 papers). Tze-Peng Lim is often cited by papers focused on Antibiotic Resistance in Bacteria (27 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Antibiotic Use and Resistance (7 papers). Tze-Peng Lim collaborates with scholars based in Singapore, United States and France. Tze-Peng Lim's co-authors include Andrea Lay‐Hoon Kwa, Jianping Xie, David Tai Leong, Magdiel Inggrid Setyawati, Kaiyuan Zheng, Jocelyn Qi-Min Teo, Winnie Lee, Yiying Cai, Thuan-Tong Tan and Thean Yen Tan and has published in prestigious journals such as ACS Nano, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tze-Peng Lim

33 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tze-Peng Lim Singapore 16 506 357 234 205 151 34 944
Füsun Cömert Türkiye 17 340 0.7× 165 0.5× 48 0.2× 233 1.1× 141 0.9× 51 910
Satoshi Minami Japan 15 302 0.6× 228 0.6× 224 1.0× 68 0.3× 114 0.8× 37 803
Heidi H. Yu Australia 19 639 1.3× 323 0.9× 24 0.1× 193 0.9× 239 1.6× 44 1.1k
Nafia Canan Gürsoy Türkiye 11 358 0.7× 91 0.3× 50 0.2× 80 0.4× 117 0.8× 23 572
Dongdong Zhao China 15 423 0.8× 80 0.2× 43 0.2× 150 0.7× 197 1.3× 49 802
Davood Kalantar-Neyestanaki Iran 19 397 0.8× 51 0.1× 90 0.4× 149 0.7× 348 2.3× 79 987
Sue C. Nang Australia 12 564 1.1× 191 0.5× 26 0.1× 112 0.5× 255 1.7× 19 979
K Prashanth India 18 463 0.9× 59 0.2× 71 0.3× 96 0.5× 394 2.6× 44 864

Countries citing papers authored by Tze-Peng Lim

Since Specialization
Citations

This map shows the geographic impact of Tze-Peng Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tze-Peng Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tze-Peng Lim more than expected).

Fields of papers citing papers by Tze-Peng Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tze-Peng Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tze-Peng Lim. The network helps show where Tze-Peng Lim may publish in the future.

Co-authorship network of co-authors of Tze-Peng Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Tze-Peng Lim. A scholar is included among the top collaborators of Tze-Peng Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tze-Peng Lim. Tze-Peng Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zhong, et al.. (2025). In vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates collected from two general hospitals in Singapore. International Journal of Antimicrobial Agents. 65(4). 107447–107447. 2 indexed citations
3.
Mok, Darren Z. L., Jia Xin Yee, C Tham, et al.. (2024). Electron transport chain capacity expands yellow fever vaccine immunogenicity. EMBO Molecular Medicine. 16(6). 1310–1323. 1 indexed citations
4.
6.
Cai, Yiying, Jocelyn Qi-Min Teo, Tze-Peng Lim, et al.. (2020). Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study. Antibiotics. 9(8). 451–451. 16 indexed citations
7.
8.
Lim, Tze-Peng, Jocelyn Qi-Min Teo, Tse-Hsien Koh, et al.. (2020). In Vitro Pharmacodynamics of Fosfomycin against Carbapenem-Resistant Enterobacter cloacae and Klebsiella aerogenes. Antimicrobial Agents and Chemotherapy. 64(9). 4 indexed citations
9.
Tam, Vincent H., Lawrence Lee, Tat Ming Ng, et al.. (2020). Performance of Population Pharmacokinetic Models in Predicting Polymyxin B Exposures. Microorganisms. 8(11). 1814–1814. 6 indexed citations
10.
Zheng, Shuwei, et al.. (2020). Impact of formulary interventions on the minimum inhibitory concentration of methicillin-resistant Staphylococcus aureus to mupirocin, chlorhexidine, and octenidine in a Singapore tertiary institution. European Journal of Clinical Microbiology & Infectious Diseases. 39(12). 2397–2403. 2 indexed citations
11.
Teo, Jocelyn Qi-Min, et al.. (2019). Molecular mechanisms of azole resistance in Candida bloodstream isolates. BMC Infectious Diseases. 19(1). 63–63. 44 indexed citations
12.
Lee, Winnie, et al.. (2019). In vitro Pharmacodynamics and PK/PD in Animals. Advances in experimental medicine and biology. 1145. 105–116. 6 indexed citations
13.
Lim, Tze-Peng, Tse-Hsien Koh, Thean Yen Tan, et al.. (2018). Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections. Infection and Drug Resistance. Volume 11. 1591–1596. 5 indexed citations
14.
Teo, Jocelyn Qi-Min, Ai‐Ling Tan, Yiying Cai, et al.. (2017). Candidemia in a major regional tertiary referral hospital – epidemiology, practice patterns and outcomes. Antimicrobial Resistance and Infection Control. 6(1). 27–27. 21 indexed citations
15.
Teo, Jocelyn Qi-Min, et al.. (2016). Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot. Microorganisms. 4(1). 13–13. 33 indexed citations
17.
Teo, Jocelyn Qi-Min, Rick Twee‐Hee Ong, Tse-Hsien Koh, et al.. (2016). mcr-1 in Multidrug-Resistant bla KPC-2 -Producing Clinical Enterobacteriaceae Isolates in Singapore. Antimicrobial Agents and Chemotherapy. 60(10). 6435–6437. 23 indexed citations
18.
Lim, Tze-Peng, Winnie Lee, Thean Yen Tan, et al.. (2011). Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B. PLoS ONE. 6(12). e28177–e28177. 50 indexed citations
19.
Lim, Tze-Peng, Thean Yen Tan, Winnie Lee, et al.. (2011). In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore. PLoS ONE. 6(4). e18485–e18485. 53 indexed citations
20.
Lim, Tze-Peng, Thean Yen Tan, Winnie Lee, et al.. (2009). In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore. The Journal of Antibiotics. 62(12). 675–679. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026